2023 was a bad year for deal-making. Considering the headwinds, will 2024 be better? Here are some key questions as the JPMorgan Healthcare Conference gets underway.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,